PRO Therapeutics

Private

Manchester, New HampshireHealthcare & Life Scienceshttps://pro-thera.com/

Last Round

Seed

Dec 5, 2024

Total Funding Raised

$1.8M

Company Overview

PRO Therapeutics, LLC is a regenerative medicine company that develops and commercializes tissue-engineered grafts for soft tissue repair.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinetissue engineeringrotator cuff repairbiotechmedical devicesoft tissue repairbiofabricationregenerative implantorthopedic surgerymusculoskeletal repairSBIRSTTR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PRO Therapeutics Comps

Public and private peers based on sector, stage, and business model.

PRO Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PRO Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 5, 2024
Grant	Jul 17, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Adam Jakus

Chief Executive Officer

Executive Team

PRO Therapeutics Investors

Notable investors and investment history

PRO Therapeutics investors
Investor	Rounds
Innovation Partnerships	Seed
National Institutes of Health (NIH)	Grant

View all Investors

PRO Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PRO Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PRO Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester, New Hampshire

Employee Range9

Year Founded2023

Last FundingDec 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.